BOCOM INTL: Mainland battery industry stock prices rise, focus on solid-state battery industrialization progress.
Low-altitude flights, robots, and AI are emerging scenarios that are opening up new market opportunities for solid-state batteries, accelerating industrialization and landing. It is recommended to pay attention to the progress of solid-state battery industrialization and the investment opportunities it brings.
BOCOM INTL released a research report stating that in August, the volume of domestically produced power batteries continued to grow, and exports remained stable. In August, the volume of domestically produced power batteries reached 62.5GWh, an increase of 32.4% year-on-year and 11.9% month-on-month. China's battery exports remained stable, with a total of 22.6GWh exported in that month, an increase of 23.9% year-on-year but a decrease of 2.6% month-on-month, accounting for 16.8% of the monthly sales.
The report pointed out that from August 11th to September 11th, the stock prices of Contemporary Amperex Technology (03750), Eve Energy Co., Ltd., Gotion High-tech, and CALB (03931) increased by 22.4%, 63.4%, 61.7%, and 35.6% respectively, reaching the latest target prices set by the bank. This is consistent with the bank's previous analysis, with the main driver coming from the continued high prosperity of energy storage orders and progress in the development of solid-state batteries by some companies.
The bank stated that solid-state batteries are gradually moving from the laboratory to the mass production verification stage. At the same time, emerging scenarios such as low-altitude flight, Siasun Robot & Automation, and AI are opening up new market space for solid-state batteries, accelerating industrialization and suggesting to pay attention to the progress of solid-state battery industrialization and the investment opportunities it brings.
Related Articles

Market sounds the alarm! The liquidity engine has stalled, and macroeconomic data is starting to weaken.

C HEALTH GP(08225) officially launches multiple AI-RWS research projects, leading the new track of "AI+ clinical research".

The comprehensive net asset value per share of WALNUT CAP (00905) at the end of August is approximately HK$0.289.
Market sounds the alarm! The liquidity engine has stalled, and macroeconomic data is starting to weaken.

C HEALTH GP(08225) officially launches multiple AI-RWS research projects, leading the new track of "AI+ clinical research".

The comprehensive net asset value per share of WALNUT CAP (00905) at the end of August is approximately HK$0.289.

RECOMMEND

Hong Kong Stock Concept Tracker|Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
11/09/2025

Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
11/09/2025

Anti-Involution Policies Deliver Results as August Price Indicators Improve
11/09/2025